Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Jeffrey Swigris

Concepts (370)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Idiopathic Pulmonary Fibrosis
67
2025
653
12.540
 Why?
Lung Diseases, Interstitial
59
2025
634
10.920
 Why?
Quality of Life
47
2025
2870
6.550
 Why?
Dyspnea
28
2025
251
6.050
 Why?
Pulmonary Fibrosis
26
2025
400
5.860
 Why?
Cough
10
2024
121
3.770
 Why?
Oxygen Inhalation Therapy
13
2021
160
3.600
 Why?
Surveys and Questionnaires
38
2025
5772
3.060
 Why?
Vital Capacity
33
2025
309
2.990
 Why?
Connective Tissue Diseases
13
2019
84
2.400
 Why?
Alveolitis, Extrinsic Allergic
6
2024
97
1.950
 Why?
Lymphangioleiomyomatosis
6
2024
35
1.830
 Why?
Arthritis, Rheumatoid
12
2024
1163
1.810
 Why?
Pyridones
12
2023
168
1.760
 Why?
Patient Reported Outcome Measures
7
2024
403
1.650
 Why?
Anti-Inflammatory Agents, Non-Steroidal
11
2021
350
1.560
 Why?
Indoles
6
2024
415
1.500
 Why?
Patient Outcome Assessment
3
2021
132
1.470
 Why?
Severity of Illness Index
20
2025
2838
1.430
 Why?
Sarcoidosis
5
2021
159
1.420
 Why?
Humans
163
2025
137514
1.340
 Why?
Aged
69
2025
23798
1.310
 Why?
Middle Aged
81
2025
33355
1.300
 Why?
Lung
21
2024
4066
1.290
 Why?
Pulmonary Medicine
3
2022
85
1.270
 Why?
Fatigue
9
2024
329
1.250
 Why?
Walking
7
2013
516
1.170
 Why?
Respiratory Function Tests
18
2024
596
1.090
 Why?
Oxygen
7
2023
943
1.080
 Why?
Psychometrics
10
2022
723
1.050
 Why?
Patients
3
2018
175
1.020
 Why?
Male
90
2025
67718
1.010
 Why?
Hypertension, Pulmonary
6
2023
1903
0.990
 Why?
Health Care Costs
3
2018
387
0.980
 Why?
Female
93
2025
73162
0.980
 Why?
Exercise Test
9
2024
621
0.960
 Why?
Research Design
5
2016
1116
0.950
 Why?
Health Status Indicators
4
2014
171
0.940
 Why?
Patient-Centered Care
2
2021
527
0.900
 Why?
Activities of Daily Living
6
2022
414
0.900
 Why?
Tomography, X-Ray Computed
18
2025
2681
0.870
 Why?
Reproducibility of Results
18
2024
3292
0.860
 Why?
Disease Progression
19
2024
2755
0.860
 Why?
Exercise Tolerance
4
2020
278
0.840
 Why?
Mycophenolic Acid
4
2016
117
0.780
 Why?
Caregivers
4
2019
872
0.760
 Why?
Forced Expiratory Volume
12
2023
532
0.740
 Why?
Internet
2
2016
656
0.720
 Why?
Organizational Objectives
1
2021
73
0.720
 Why?
Patient Satisfaction
3
2021
657
0.710
 Why?
Nursing Research
1
2021
48
0.700
 Why?
Lactic Acid
1
2022
306
0.660
 Why?
Pulmonary Emphysema
2
2024
290
0.660
 Why?
Symptom Assessment
1
2020
126
0.640
 Why?
Rhinitis, Allergic
1
2020
38
0.640
 Why?
Undifferentiated Connective Tissue Diseases
1
2019
1
0.640
 Why?
Chronic Disease
5
2022
1790
0.630
 Why?
Fatty Acids
1
2022
445
0.600
 Why?
Pulmonary Disease, Chronic Obstructive
4
2022
1042
0.590
 Why?
Emphysema
1
2018
109
0.560
 Why?
Needs Assessment
2
2019
368
0.550
 Why?
Particulate Matter
1
2020
314
0.540
 Why?
Patient Education as Topic
3
2019
766
0.540
 Why?
Longitudinal Studies
9
2020
2857
0.530
 Why?
Autoimmune Diseases
4
2019
459
0.530
 Why?
Lung Diseases
3
2015
768
0.520
 Why?
Aged, 80 and over
19
2021
7593
0.520
 Why?
Pulmonary Diffusing Capacity
7
2019
75
0.510
 Why?
Qualitative Research
4
2017
1361
0.510
 Why?
Lung Transplantation
1
2019
309
0.500
 Why?
Heart Rate
2
2011
831
0.490
 Why?
United States
25
2024
14696
0.490
 Why?
Treatment Outcome
20
2023
10821
0.490
 Why?
Information Seeking Behavior
1
2016
33
0.480
 Why?
Idiopathic Interstitial Pneumonias
6
2017
49
0.480
 Why?
Immunosuppressive Agents
4
2016
891
0.480
 Why?
Exercise
4
2022
2024
0.480
 Why?
Adult
39
2024
37821
0.480
 Why?
Ambulatory Care
2
2018
539
0.470
 Why?
Gastroesophageal Reflux
2
2021
235
0.470
 Why?
Narration
1
2016
58
0.470
 Why?
Air Pollutants
1
2020
428
0.460
 Why?
Double-Blind Method
10
2024
1987
0.460
 Why?
Prognosis
15
2024
4031
0.450
 Why?
Mental Health
2
2020
724
0.450
 Why?
Kaplan-Meier Estimate
8
2018
892
0.440
 Why?
Telemedicine
1
2023
852
0.440
 Why?
Autoimmunity
2
2019
907
0.430
 Why?
Antibodies, Monoclonal
1
2021
1428
0.420
 Why?
Retrospective Studies
26
2025
15628
0.420
 Why?
Biomedical Research
2
2018
689
0.420
 Why?
Autoantibodies
6
2023
1501
0.420
 Why?
Antitussive Agents
1
2013
7
0.410
 Why?
Lung Neoplasms
4
2024
2494
0.400
 Why?
Thalidomide
1
2013
40
0.400
 Why?
Bronchiolitis Obliterans
1
2013
69
0.400
 Why?
Social Media
1
2016
157
0.400
 Why?
Social Support
2
2019
616
0.390
 Why?
Survival Rate
7
2019
1980
0.390
 Why?
Physicians
2
2019
904
0.390
 Why?
Motivation
1
2017
571
0.380
 Why?
Bronchial Diseases
1
2012
37
0.380
 Why?
Patient Participation
1
2015
423
0.370
 Why?
Follow-Up Studies
9
2018
5139
0.360
 Why?
Quality Indicators, Health Care
1
2014
310
0.350
 Why?
Oxygen Consumption
3
2022
684
0.350
 Why?
Scleroderma, Systemic
4
2019
122
0.350
 Why?
Health Knowledge, Attitudes, Practice
2
2018
1332
0.350
 Why?
Health Status
5
2019
784
0.340
 Why?
Multivariate Analysis
5
2017
1524
0.340
 Why?
Peptides, Cyclic
1
2012
260
0.340
 Why?
Hospitalization
3
2017
2197
0.330
 Why?
Protein Kinase Inhibitors
3
2021
920
0.330
 Why?
Endothelins
1
2010
64
0.320
 Why?
Motor Activity
1
2014
723
0.320
 Why?
Cause of Death
6
2019
431
0.310
 Why?
Diagnosis, Differential
7
2019
1486
0.310
 Why?
Pulmonologists
2
2019
15
0.300
 Why?
Registries
4
2025
2021
0.300
 Why?
Pulmonary Embolism
1
2011
222
0.300
 Why?
Proportional Hazards Models
4
2019
1263
0.300
 Why?
Cohort Studies
8
2025
5730
0.300
 Why?
Amino Acyl-tRNA Synthetases
3
2016
30
0.290
 Why?
Endothelin-1
1
2010
181
0.290
 Why?
TRPP Cation Channels
1
2009
84
0.290
 Why?
Asthma
2
2020
2290
0.290
 Why?
Polycystic Kidney Diseases
1
2009
76
0.280
 Why?
Palliative Care
3
2019
738
0.280
 Why?
Sleep Apnea, Obstructive
1
2012
291
0.280
 Why?
Prospective Studies
9
2021
7598
0.280
 Why?
Sirolimus
2
2023
275
0.270
 Why?
Randomized Controlled Trials as Topic
5
2017
1465
0.260
 Why?
Vascular Endothelial Growth Factor D
3
2023
13
0.260
 Why?
Consensus
2
2024
685
0.260
 Why?
Bronchoalveolar Lavage Fluid
2
2025
654
0.260
 Why?
Sex Distribution
3
2012
378
0.260
 Why?
Exercise Therapy
3
2024
435
0.260
 Why?
Tumor Suppressor Proteins
1
2009
328
0.260
 Why?
Biopsy
7
2016
1132
0.250
 Why?
Home Care Services
2
2020
254
0.250
 Why?
Prevalence
5
2018
2719
0.250
 Why?
Mortality
4
2019
357
0.250
 Why?
Cost of Illness
3
2018
304
0.250
 Why?
Myositis
3
2019
52
0.240
 Why?
Patient Advocacy
2
2024
75
0.240
 Why?
Quality Improvement
1
2014
1161
0.240
 Why?
Lupus Erythematosus, Systemic
1
2008
257
0.230
 Why?
Thrombosis
1
2008
368
0.220
 Why?
Minimal Clinically Important Difference
2
2021
15
0.220
 Why?
Fibrosis
2
2024
552
0.210
 Why?
Time Factors
7
2019
6817
0.210
 Why?
Age Distribution
3
2019
391
0.210
 Why?
Databases, Factual
3
2019
1351
0.210
 Why?
Delphi Technique
1
2024
273
0.200
 Why?
Respiratory Therapy
2
2019
23
0.190
 Why?
Evidence-Based Medicine
2
2020
746
0.190
 Why?
Sex Factors
6
2019
2074
0.190
 Why?
Receptors, Lysophosphatidic Acid
1
2021
30
0.190
 Why?
Environmental Exposure
2
2020
575
0.180
 Why?
Patient Care Management
1
2021
56
0.180
 Why?
Incidence
3
2018
2792
0.170
 Why?
Analysis of Variance
3
2015
1324
0.170
 Why?
Survival Analysis
3
2017
1320
0.170
 Why?
Linear Models
3
2019
851
0.170
 Why?
Focus Groups
3
2016
512
0.170
 Why?
Interleukin-13
1
2021
149
0.160
 Why?
Logistic Models
4
2019
2064
0.160
 Why?
Antibodies, Antinuclear
4
2016
71
0.160
 Why?
Pain Measurement
1
2022
552
0.160
 Why?
Walk Test
2
2017
75
0.160
 Why?
Risk Factors
8
2021
10356
0.160
 Why?
Sensitivity and Specificity
3
2015
1950
0.160
 Why?
Chi-Square Distribution
2
2011
533
0.150
 Why?
Terminal Care
2
2019
224
0.150
 Why?
Allied Health Personnel
1
2019
46
0.150
 Why?
General Practitioners
1
2019
28
0.150
 Why?
Insurance Claim Review
1
2018
63
0.150
 Why?
Immunoglobulin A
1
2019
210
0.150
 Why?
Lipid Metabolism
1
2022
511
0.150
 Why?
Oxidation-Reduction
1
2022
1059
0.140
 Why?
Accelerometry
2
2019
97
0.140
 Why?
Anxiety
3
2019
1041
0.140
 Why?
Cellular Senescence
1
2019
188
0.140
 Why?
Physician Assistants
1
2019
92
0.140
 Why?
Weight-Bearing
1
2018
167
0.130
 Why?
Cross-Sectional Studies
4
2019
5427
0.130
 Why?
Attitude to Health
2
2014
444
0.130
 Why?
Germany
1
2017
121
0.130
 Why?
Nurse Practitioners
1
2019
135
0.130
 Why?
Allergens
1
2020
407
0.130
 Why?
Perception
1
2019
360
0.130
 Why?
Sulfonamides
2
2010
513
0.130
 Why?
Medicare
2
2018
747
0.130
 Why?
Common Variable Immunodeficiency
1
2016
29
0.130
 Why?
Antihypertensive Agents
2
2010
493
0.130
 Why?
Tidal Volume
1
2016
86
0.130
 Why?
Nurses
1
2019
174
0.130
 Why?
Host-Pathogen Interactions
1
2019
367
0.120
 Why?
Granuloma
1
2016
91
0.120
 Why?
Clinical Trials as Topic
3
2024
1047
0.120
 Why?
Cyclophosphamide
1
2016
251
0.120
 Why?
Muscle Strength
2
2015
315
0.120
 Why?
Health Policy
1
2018
388
0.120
 Why?
Physical Conditioning, Human
1
2015
40
0.120
 Why?
Rituximab
1
2016
178
0.120
 Why?
Interviews as Topic
2
2016
767
0.110
 Why?
Neuroendocrine Cells
1
2015
32
0.110
 Why?
Geographic Information Systems
1
2014
43
0.110
 Why?
Nitric Oxide
1
2020
914
0.110
 Why?
Recovery of Function
1
2018
662
0.110
 Why?
Case-Control Studies
4
2019
3546
0.110
 Why?
Sarcoidosis, Pulmonary
1
2015
83
0.110
 Why?
Enzyme Inhibitors
2
2016
845
0.110
 Why?
Societies, Medical
5
2020
820
0.110
 Why?
Controlled Clinical Trials as Topic
1
2013
28
0.110
 Why?
Sildenafil Citrate
1
2013
58
0.110
 Why?
Antifibrinolytic Agents
1
2014
51
0.110
 Why?
Information Dissemination
1
2016
218
0.100
 Why?
Carbon Monoxide
3
2019
80
0.100
 Why?
Sulfones
1
2013
110
0.100
 Why?
Endpoint Determination
1
2013
77
0.100
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2013
41
0.100
 Why?
Predictive Value of Tests
3
2024
2039
0.100
 Why?
Phenotype
2
2018
3205
0.100
 Why?
Antibiotics, Antineoplastic
1
2013
130
0.100
 Why?
Purines
1
2013
176
0.100
 Why?
Patient Dropouts
1
2013
67
0.100
 Why?
Practice Guidelines as Topic
1
2020
1580
0.100
 Why?
Self Report
2
2019
831
0.100
 Why?
Smoking
3
2019
1639
0.100
 Why?
Adaptation, Psychological
1
2017
653
0.090
 Why?
Occupational Exposure
1
2016
342
0.090
 Why?
Pulmonary Gas Exchange
1
2012
121
0.090
 Why?
Histocompatibility Antigens Class II
1
2013
368
0.090
 Why?
Health Care Surveys
1
2014
567
0.090
 Why?
Vasodilator Agents
1
2013
333
0.090
 Why?
Dust
1
2012
100
0.090
 Why?
Minnesota
1
2012
161
0.090
 Why?
Delivery of Health Care
1
2018
948
0.090
 Why?
Piperazines
1
2013
351
0.090
 Why?
Clinical Competence
1
2019
1093
0.090
 Why?
United Kingdom
1
2012
324
0.090
 Why?
Fear
1
2014
354
0.090
 Why?
Young Adult
5
2017
13243
0.090
 Why?
Hydrogen-Ion Concentration
1
2012
566
0.090
 Why?
Epidemiologic Methods
1
2010
96
0.080
 Why?
Health Surveys
1
2012
520
0.080
 Why?
Anti-Infective Agents
1
2013
256
0.080
 Why?
Sickness Impact Profile
2
2009
56
0.080
 Why?
Pilot Projects
2
2015
1703
0.080
 Why?
Salivary Glands, Minor
1
2009
11
0.080
 Why?
Sjogren's Syndrome
1
2009
54
0.080
 Why?
Hyperplasia
2
2015
175
0.080
 Why?
International Cooperation
3
2015
198
0.080
 Why?
Scleroderma, Limited
1
2008
5
0.070
 Why?
Oximetry
1
2009
96
0.070
 Why?
Risk
1
2011
905
0.070
 Why?
Europe
3
2015
414
0.070
 Why?
Poisson Distribution
3
2016
75
0.070
 Why?
Cardiac Catheterization
1
2011
528
0.070
 Why?
Sleep Wake Disorders
1
2011
283
0.070
 Why?
Radiography
2
2016
834
0.070
 Why?
Wound Healing
1
2010
327
0.070
 Why?
Comorbidity
2
2017
1618
0.070
 Why?
Pericardium
1
2007
56
0.070
 Why?
Depression
2
2019
1408
0.070
 Why?
Models, Statistical
1
2011
667
0.070
 Why?
Clinical Trials, Phase III as Topic
2
2016
105
0.060
 Why?
Medical Records
1
2006
173
0.060
 Why?
Seasons
1
2008
546
0.060
 Why?
Regression Analysis
3
2016
1029
0.060
 Why?
Singapore
1
2024
22
0.060
 Why?
California
1
2005
425
0.050
 Why?
Bronchoscopy
1
2025
222
0.050
 Why?
Echocardiography
1
2007
659
0.050
 Why?
Acute Disease
1
2006
1008
0.050
 Why?
Dose-Response Relationship, Drug
2
2020
2066
0.050
 Why?
Data Interpretation, Statistical
2
2018
352
0.050
 Why?
National Institutes of Health (U.S.)
1
2024
129
0.050
 Why?
ROC Curve
1
2025
547
0.050
 Why?
Terminology as Topic
1
2005
216
0.050
 Why?
Lymphoid Tissue
1
2002
75
0.050
 Why?
Rheumatologists
1
2022
16
0.050
 Why?
Whole Genome Sequencing
1
2023
152
0.050
 Why?
Exome
1
2023
231
0.050
 Why?
Age Factors
3
2019
3301
0.050
 Why?
Lysophospholipids
1
2021
80
0.040
 Why?
Patient Care
1
2022
111
0.040
 Why?
Telomere
1
2024
280
0.040
 Why?
Patient Selection
1
2005
691
0.040
 Why?
Attitude
1
2022
262
0.040
 Why?
Total Lung Capacity
1
2019
33
0.040
 Why?
Genomics
1
2025
793
0.040
 Why?
Adolescent
3
2017
21555
0.040
 Why?
Occupations
1
2019
48
0.040
 Why?
Pulmonary Surfactant-Associated Protein A
1
2019
35
0.040
 Why?
Disease Models, Animal
1
2010
4295
0.040
 Why?
Pulmonary Surfactant-Associated Protein C
1
2019
45
0.040
 Why?
GTPase-Activating Proteins
1
2019
82
0.040
 Why?
Blood Gas Analysis
1
2019
74
0.040
 Why?
Exoribonucleases
1
2019
49
0.040
 Why?
ATP-Binding Cassette Transporters
1
2019
138
0.040
 Why?
Education
1
2018
108
0.040
 Why?
Administration, Inhalation
1
2020
683
0.040
 Why?
Watchful Waiting
1
2018
80
0.040
 Why?
DNA Helicases
1
2019
150
0.040
 Why?
Administrative Claims, Healthcare
1
2017
26
0.040
 Why?
Telomere-Binding Proteins
1
2019
122
0.040
 Why?
Physical Endurance
1
2019
275
0.030
 Why?
Forecasting
1
2019
386
0.030
 Why?
Mucin-5B
1
2019
224
0.030
 Why?
Telomerase
1
2019
250
0.030
 Why?
Hypersplenism
1
2016
8
0.030
 Why?
Leukopenia
1
2016
31
0.030
 Why?
Spirometry
1
2017
281
0.030
 Why?
Algorithms
1
2024
1702
0.030
 Why?
Banking, Personal
1
2016
2
0.030
 Why?
Sequence Analysis, DNA
1
2019
812
0.030
 Why?
Health Care Sector
1
2016
24
0.030
 Why?
Death Certificates
1
2016
30
0.030
 Why?
Rheumatoid Factor
1
2017
175
0.030
 Why?
Creatine Kinase
1
2016
79
0.030
 Why?
Mass Screening
1
2024
1264
0.030
 Why?
Social Participation
1
2016
25
0.030
 Why?
Health Services Needs and Demand
1
2017
270
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2019
538
0.030
 Why?
Arthritis
1
2016
95
0.030
 Why?
Biomarkers
2
2019
4172
0.030
 Why?
Commerce
1
2016
80
0.030
 Why?
International Classification of Diseases
1
2016
131
0.030
 Why?
Multiple Pulmonary Nodules
1
2015
22
0.030
 Why?
Metals
1
2016
136
0.030
 Why?
Anthropometry
1
2015
214
0.030
 Why?
Promoter Regions, Genetic
1
2019
1255
0.030
 Why?
Physical Examination
1
2016
241
0.030
 Why?
Pandemics
1
2023
1619
0.030
 Why?
Disease-Free Survival
1
2016
690
0.030
 Why?
Genetic Variation
1
2019
986
0.030
 Why?
Alberta
1
2013
27
0.030
 Why?
Bronchiolitis
1
2015
91
0.030
 Why?
Mortality, Premature
1
2013
14
0.030
 Why?
Teaching
1
2016
226
0.030
 Why?
Odds Ratio
1
2016
1063
0.030
 Why?
Counseling
1
2016
393
0.030
 Why?
Drug Therapy, Combination
1
2016
1060
0.020
 Why?
Adrenal Cortex Hormones
1
2016
555
0.020
 Why?
RNA
1
2019
924
0.020
 Why?
Genome-Wide Association Study
1
2019
1436
0.020
 Why?
Congresses as Topic
1
2013
233
0.020
 Why?
Administration, Oral
1
2014
814
0.020
 Why?
Inflammation
1
2002
2837
0.020
 Why?
Antigens, Human Platelet
1
2011
9
0.020
 Why?
Japan
1
2011
116
0.020
 Why?
Latin America
1
2011
96
0.020
 Why?
Genetic Predisposition to Disease
1
2019
2420
0.020
 Why?
Alanine-tRNA Ligase
1
2009
4
0.020
 Why?
Threonine-tRNA Ligase
1
2009
5
0.020
 Why?
Psychiatric Status Rating Scales
1
2011
555
0.020
 Why?
DNA Topoisomerases, Type I
1
2008
14
0.020
 Why?
Syndrome
1
2009
359
0.020
 Why?
Animals
1
2010
37011
0.020
 Why?
Cell Proliferation
1
2015
2482
0.020
 Why?
Pulmonary Wedge Pressure
1
2007
69
0.020
 Why?
Lymphocytes
1
2009
395
0.020
 Why?
Body Mass Index
1
2015
2369
0.020
 Why?
Risk Assessment
1
2015
3439
0.020
 Why?
Muscle, Skeletal
1
2015
1701
0.010
 Why?
Nuclear Proteins
1
2008
710
0.010
 Why?
Child
1
2002
22037
0.010
 Why?
Pneumonia
1
2008
638
0.010
 Why?
Swigris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (370) concept(s)
_
Co-Authors Expand Description
See all (37) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)